$IOVA Steven A. Rosenberg, considered the Father of Cancer Immunotherapy, has received the 2026 Tang Prize in Biopharmaceutical Science.
Steven, a pioneer in the utilisation of IL-2 and the development of TILs, is a member of @IovanceBio's network of research partners and